Business Wire

Clear Creek Bio Advances Its Highly Potent SARS-CoV-2 PLpro Inhibitors in Discovery of an Oral Direct-Acting Antiviral to Treat COVID-19

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Clear Creek Bio, Inc. announced today that the company has signed a Cooperative Research and Development Agreement (CRADA) with the National Center for Advancing ...
Business Wire

Clear Creek Bio Doses First Patient in Phase 2 Outpatient Study of Brequinar to Treat COVID-19

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Clear Creek Bio, Inc. announced today that the company has dosed the first patient in the CRISIS2 study, a Phase 2 clinical study evaluating brequinar for the ...
Yahoo

Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug

FILE PHOTO: A syringe is filled with a dose of Pfizer's coronavirus disease (COVID-19) vaccine at a pop-up community vaccination center in Valley Stream, New York (Reuters) - Pfizer Inc and Clear ...
MassLive

Clear Creek Bio partners with Pfizer to make antiviral COVID pills

Pfizer’s fight against COVID-19 continues as the company plans a collaboration with Cambridge startup Clear Creek Bio to develop new antiviral pills. It was announced Tuesday that the collaboration ...
Nasdaq

Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease

Agreement aims to advance discovery and development of novel papain-like protease (PLpro) inhibitors and potentially introduce a new class of oral antivirals in the fight against COVID-19 Expands ...
Nasdaq

Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug

Dec 6 (Reuters) - Pfizer Inc PFE.N and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as ...